RightFit Trial Directory

Colorectal Cancer clinical trials in Baltimore, MD

19 recruiting colorectal cancer studies with a site in Baltimore, MD.

All trials in Baltimore, MD · All Colorectal Cancer trials

RecruitingPhase 1 / Phase 2NCT07020221

A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors

Sponsor: Verastem, Inc.

Baltimore, MD · +12 more sites

RecruitingPhase 2NCT07023289

A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease

Sponsor: AbbVie

Baltimore, MD · +21 more sites

RecruitingPhase 3NCT07222800

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Sponsor: Pfizer

Baltimore, MD · +253 more sites

RecruitingPhase 1 / Phase 2NCT05919264

FOG-001 in Locally Advanced or Metastatic Solid Tumors

Sponsor: Parabilis Medicines, Inc.

Baltimore, MD · +30 more sites

RecruitingPhase 3NCT06997497

A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)

Sponsor: Merck Sharp & Dohme LLC

Baltimore, MD · +46 more sites

RecruitingPhase 3NCT07228832

Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

Sponsor: Summit Therapeutics

Baltimore, MD · +111 more sites

RecruitingPhase 2NCT05673148

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial

Sponsor: Alliance for Clinical Trials in Oncology

Baltimore, MD · +187 more sites

RecruitingPhase 1 / Phase 2NCT06445062

Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors

Sponsor: Revolution Medicines, Inc.

Baltimore, MD · +31 more sites

RecruitingPhase 1 / Phase 2NCT06638502

Safety of HRX215 in Patients After Minor and Major Liver Resection

Sponsor: HepaRegeniX GmbH

Baltimore, MD · +3 more sites

RecruitingPhase 1 / Phase 2NCT07147231

Testing the Effectiveness of the Anti-cancer Drug Pidnarulex (CX-5461), in Combination With Another Anti-cancer Drug Cemiplimab (REGN2810), in Treating Refractory Microsatellite Stable Colorectal Cancer

Sponsor: National Cancer Institute (NCI)

Baltimore, MD · +5 more sites

RecruitingPhase 2NCT06792695

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Sponsor: AstraZeneca

Baltimore, MD · +13 more sites

RecruitingPhase 1NCT06179160

A Study to Evaluate INCB161734 in Participants With Advanced or Metastatic Solid Tumors With KRAS G12D Mutation

Sponsor: Incyte Corporation

Baltimore, MD · +12 more sites

RecruitingPhase 3NCT06950385

Phase 3 Trial of eRapa in Patients With Familial Adenomatous Polyposis

Sponsor: Rapamycin Holdings Inc.

Baltimore, MD · +17 more sites

RecruitingPhase 1 / Phase 2NCT05379985

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Sponsor: Revolution Medicines, Inc.

Baltimore, MD · +20 more sites

RecruitingPhase 2NCT06205836

Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, MD

RecruitingPhase 2NCT07033026

An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.

Sponsor: NGM Biopharmaceuticals, Inc

Baltimore, MD · +12 more sites

RecruitingPhase 1NCT06778863

A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation

Sponsor: Clasp Therapeutics, Inc.

Baltimore, MD · +20 more sites

RecruitingPhase 3NCT02000089

The Cancer of the Pancreas Screening-5 CAPS5)Study

Sponsor: Johns Hopkins University

Baltimore, MD · +8 more sites

Not yet recruitingPhase 2NCT07580339

Combining DCSZ11 With Radiation and Chemotherapy as Neoadjuvant Treatment for pMMR Locally Advanced Rectal Cancer

Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Baltimore, MD

Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.